ARCHIVES

No Longer A Hands-Off Shareholder, Roche Seeks Full Control Of Genentech.

This article is from The Cancer Letter archive.

Vol. 34 No. 29 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

Murray Copeland Display Dedicated

March 18, 1983

Costs of Rosenberg Regimen Could Hinder cooperative Group Trials

January 3, 1986

In Brief: FDA Names DeLap Directory Of Oncology

June 7, 1996

In Brief: Clinical Education Program to Be Phased Out; Ken Endicott Retires From Grupenhoff Firm

January 31, 1986

In Brief: Henney To Leave NCI For Kansas; Dan Longo Heads BRMP; DeVita To Receive Nervi Award

May 10, 1985

Taking Profit Out Of ESAs, Insurer Sending Controversial Drugs Directly To Patients.

April 9, 2010